Autolus Therapeutics Ltd | AUTL - Cost Of Sales

Stock Price
1.67
Daily Change
-0.10 -5.65%
Monthly
15.17%
Yearly
-3.47%
Q1 Forecast
1.64

Autolus Therapeutics Ltd reported $24.91M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
AstraZeneca USD 3.27B 471M Dec/2025
Autolus Therapeutics Ltd USD 24.91M 6.96M Jun/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Novartis USD 3.54B 217M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Silence Therapeutics USD 2.77M 136K Sep/2024